Göran Tornling
Direktor/Vorstandsmitglied bei ACUCORT AB
Aktive Positionen von Göran Tornling
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ACUCORT AB | Direktor/Vorstandsmitglied | 01.01.2021 | - |
| Independent Dir/Board Member | 01.01.2021 | - | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2006 | - |
| Karolinska Institutet | Corporate Officer/Principal | - | - |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
AnaMar AB
 AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Karriereverlauf von Göran Tornling
Ehemalige bekannte Positionen von Göran Tornling
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
AstraZeneca R&D Boston, Inc.
 AstraZeneca R&D Boston, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca R&D Boston, Inc. develops, manufactures and markets prescription pharmaceutical drugs. The company is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Ausbildung von Göran Tornling
| Karolinska Institutet | Doctorate Degree |
Statistik
International
| Schweden | 6 |
| Vereinigte Staaten | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ACUCORT AB | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Health Technology |
AstraZeneca R&D Boston, Inc.
AstraZeneca R&D Boston, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca R&D Boston, Inc. develops, manufactures and markets prescription pharmaceutical drugs. The company is headquartered in Cambridge, MA. | Health Technology |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Health Technology |
AnaMar AB
AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Health Technology |
- Börse
- Insiders
- Göran Tornling
- Erfahrung
